TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Clinical trial NCT01493505 · TERMINATED
Trial details
- NCT number
- NCT01493505
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 1015
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.